
Apartment rents drop in July as vacancies move to multi-year high
The national multifamily vacancy rate rose to 7.1% in July, setting a new record on Apartment List's monthly index, which goes back to 2017. The report notes that while the market has passed the peak of this latest construction boom, it is still overbuilt relative to demand.
Landlords are not quite as overstocked as they were at the start of this year, but it is still more of a renter's market. Last year more than 600,000 new multifamily units hit the market, representing a 65% increase compared to 2022 and the most new supply in a single year since 1986, Apartment List found.
For July, it took an average of 28 days to lease units after they were listed, according to the report, slightly longer than in June but down from the recent high of 37 days seen in January.
Rents nationally were unchanged in July compared with June; the median rent was $1,402, according to Apartment List. Rents peaked earlier this year, and rent growth has now stalled during the peak moving season when growth is usually fastest.
Rents this month were down 0.8% from the same month last year, according to the report. They had been approaching positive annual growth early this year but have now been negative for three straight months, according to Apartment List data.
CNBC's Property Play with Diana Olick covers new and evolving opportunities for the real estate investor, delivered weekly to your inbox.
Subscribe here to get access today.
"All of our key indicators are pointing toward ongoing sluggishness in the multifamily rental market – rent growth is slipping and the vacancy rate is at an all-time high," the report said. "A return to tighter market conditions should still be on the horizon, but the outlook has been complicated by macroeconomic whiplash being caused by tariffs and other policies being pursued by the Trump administration. That uncertainty appears to have modestly dampened demand during this moving season."
Regionally, rents were up in July from June in 37 of the nation's 54 metropolitan areas with a population of more than 1 million, Apartment List found. Less than half of these cities, however, are seeing positive rent growth compared with a year ago. Rent declines are most prevalent in the formerly very hot South and in the Mountain West, according to the report.
Austin, Texas, wins the dubious award of being the nation's softest rental market, with rents there down 6.8% compared with July of last year. Denver and Phoenix weren't far behind.
On the flip side, San Francisco is seeing the biggest gains, with rents up 4.6% from last year. Other strong markets include Fresno, California, and Chicago.
"Although the supply wave is receding, the number of units that hit the market in the first half of this year was still above the long-run average. With construction expected to slow further in the second half of this year and into 2026, conditions are likely to shift," according to the report.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Susquehanna Lowers Wolfspeed (WOLF) PT to $1.50 Amid Q2 Semiconductor Preview
Wolfspeed Inc. (NYSE:WOLF) is one of the tech stocks to buy according to analysts. On July 22, Susquehanna lowered the price target for Wolfspeed from $3 to $1.50, while maintaining a Neutral rating on the shares. The adjustment came as part of the firm's Q2 preview for the semiconductor group, with the firm expecting in-line to modest upside reports for the current quarter, driven by tariff-related demand pull-ins and sustained AI strength. However, Susquehanna's analysts did note increased uncertainty for the latter half of 2025 within the broader semiconductor market. In FQ3 2025, Wolfspeed showed a sequential revenue growth of 50% at its Mohawk Valley facility, which contributed $78 million in revenue. The company has also established a fully automated 200-millimeter manufacturing footprint for silicon carbide solutions and received ~$192 million in cash tax refunds from the Section 48D advanced manufacturing tax credit, which boosted liquidity. Close-up of Silicon Die are being Extracted from Semiconductor Wafer and Attached to Substrate by Pick and Place Machine. Computer Chip Manufacturing at Fab. Semiconductor Packaging Process. Additionally, Wolfspeed is actively engaging with customers for sampling 200-millimeter materials and pursuing new contracts for 200-millimeter wafer supply. But at the same time, the company is undergoing a restructuring, which includes a 30% reduction in its senior leadership team and projected restructuring charges of $400 million to $450 million for FY2025. Free cash flow during the quarter was also negative, at $168 million. Wolfspeed Inc. (NYSE:WOLF) is a semiconductor company that focuses on silicon carbide and gallium nitride/GaN technologies in Europe, Hong Kong, China, the rest of Asia-Pacific, the US, and internationally. While we acknowledge the potential of WOLF as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
9 minutes ago
- Yahoo
MultiSensor AI Holdings Upgrades Asset Health Platform with MSAI Connect 2.0, Adds Enhanced AI, Seamless EAM Integration
MultiSensor AI Holdings Inc. (NASDAQ:MSAI) is one of the tech stocks to buy according to analysts. On July 9, MultiSensor AI Holdings unveiled MSAI Connect 2.0. This upgrade to their asset health monitoring platform further reduces unplanned downtime, streamlines operations, and provides users with more actionable insights. MSAI Connect 2.0 introduces several key enhancements. Its AI functionality is supported by camera disturbance detection, which alerts operators to unintended sensor movements that might affect critical asset monitoring. Additionally, improved person and motion detection logic has been incorporated to reduce false-positive alerts. Photo by Vishnu Mohanan on Unsplash The platform integrates seamlessly with customers' existing Enterprise Asset Management/EAM systems. This creates a link between identifying issues and initiating corrective actions. MultiSensor AI Holdings Inc. (NASDAQ:MSAI) builds and deploys intelligent multi-sensing platforms with edge and cloud software solutions that use AI in the US and internationally. While we acknowledge the potential of MSAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
Yahoo
19 minutes ago
- Yahoo
Citi Remains Bullish on Sana Biotechnology (SANA)
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the best biotech penny stocks to buy right now. Citi analyst Samantha Semenkow maintained a bullish stance on Sana Biotechnology, Inc. (NASDAQ:SANA), giving it a Buy rating on July 2 with a $15 price target. A scientist working with a microscope in a laboratory, focusing on a cell of a medical experiment. The analyst based the rating on Sana Biotechnology, Inc.'s (NASDAQ:SANA) potential in addressing notable market opportunities. Semenkow stated that the company's Type 1 Diabetes (T1D) program has exhibited considerable proof-of-concept results, with updated six-month data showing durable c-peptide production and successful graft survival without the need for immunosuppression. According to the analyst, this data consistency bolsters confidence in Sana Biotechnology, Inc.'s (NASDAQ:SANA) approach and paints a positive picture for its T1D asset, SC451, anticipated to make progress towards an IND as early as 2026. The same day, Morgan Stanley analyst Maxwell Skor also assumed coverage of Sana Biotechnology, Inc. (NASDAQ:SANA) with an Overweight rating and $12 price target. The analyst expects an investigational new drug filing as early as next year for its proprietary HIP-modified, islet stem-cell derived T1D therapy, SC451. Sana Biotechnology (NASDAQ:SANA) is a biotechnology company that specializes in using engineered cells as medicines. It develops cell engineering programs that transform treatment across several therapeutic areas with treatment gaps, including diabetes, oncology, the central nervous system, and B-cell-mediated autoimmune disorders. While we acknowledge the potential of SANA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data